COPD (chronic obstructive pulmonary disease) is a life-threatening disease that results from damage incurred to the lungs, progressively decreasing their ability to absorb oxygen. Up until now this disease, that is the number 3 cause of death in the US, had no cure or treatment. However, treatment with the ZMedicAir device has been shown to be ground breaking as it induces the healing of the lungs, leading to unprecedented improvement of the patients' lung capacity and of the other symptoms of the disease. There is no other non-invasive treatment available today that can achieve similar results.
a tightness feeling in the chest
airways blockage due to mucus buildup
difficulty doing simple tasks
dependence on oxygen therapy
serious complications due to simple flu and lung infections
Pathophysiology of COPD
COPD is a term that includes two conditions- emphysema and chronic bronchitis.
The lung tissue is made up of myriad of tiny elastic air sacs (alveoli), in which the oxygen-carbon dioxide exchange occurs. Emphysema is a result of the walls defining the alveoli getting damaged, leading to fewer and larger air sacs. As a result, the efficiency of the gas exchange in the lungs is significantly reduced.
In this condition, the lining of the airways is inflamed, this causes the lining to swell. Lots of thick mucus forms in the airways, making it hard to breathe.
The leading cause for COPD is long term exposure to chemical fumes that act as lung irritants. The main cause is smoking, but it can also be caused by air pollution and dust.
The various chemicals and particles that are inhaled with chemical fumes affect the airways and lung tissue in various ways, including by reducing the elasticity and thickness of the alveoli's walls that makes them break more easily, causing structural damage to the lungs. Also, mucus production and thickness is increased, clogging the lungs and increasing the danger of infections.
COPD can also be caused by a rare genetic condition.
ZMedicAir Device COPD Treatment
Patients treated with the singlet oxygen-enriched air produced by the ZMedicAir device reported on experiencing improvement in their condition within days of treatment. The patients treated were mostly in the late stages of the disease, being incapable of doing the simplest of tasks like walking and talking for long. The shortest exertion resulted in low oxygen blood saturation, requiring frequent oxygen supplementation. This condition greatly affected the patients' life quality as it made them mostly stationary, incapable of working or traveling.
Within days of the ZMedicAir treatment, the patients' conditions dramatically improved. Patients reported on easier breathing, being able to exert themselves for longer periods of time without requiring oxygen supplementation. Within a few weeks, patients started working and traveling again.
This improvement stems from the lungs healing themselves due to the treatment, as spirometry tests done after a month of treatment have shown a significant improvement in the lungs function, something that no other treatment that is currently in use manages to achieve.